These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analytical ultracentrifugation and the genetic engineering of macromolecules. Harding SE Biotechnol Genet Eng Rev; 1993; 11():317-56. PubMed ID: 7530960 [No Abstract] [Full Text] [Related]
4. [Transdirect insect cells]. Shimizu M; Arimura H; Kanemori Y; Miyake M; Azuma T; Kaki H; Ezure T Tanpakushitsu Kakusan Koso; 2006 Nov; 51(13):1869-78. PubMed ID: 17087358 [No Abstract] [Full Text] [Related]
5. Engineering novel proteins by transfer of active sites to natural scaffolds. Vita C Curr Opin Biotechnol; 1997 Aug; 8(4):429-34. PubMed ID: 9265721 [TBL] [Abstract][Full Text] [Related]
6. Combinatorial protein design by in vitro recombination. Giver L; Arnold FH Curr Opin Chem Biol; 1998 Jun; 2(3):335-8. PubMed ID: 9691067 [TBL] [Abstract][Full Text] [Related]
7. An overview and historical perspective of protein biotechnology. Udenfriend S Bioprocess Technol; 1990; 7():1-8. PubMed ID: 1366818 [No Abstract] [Full Text] [Related]
8. Cloning independent site-directed mutagenesis using total RNA as template. Nagy ZB; Fehér LZ; Puskás LG Biotechniques; 2004 May; 36(5):762-4, 766. PubMed ID: 15152593 [No Abstract] [Full Text] [Related]
9. Properties of artificial proteins with random sequences. Yomo T; Prijambada ID; Yamamoto K; Shima Y; Negoro S; Urabe I Ann N Y Acad Sci; 1998 Dec; 864():131-5. PubMed ID: 9928087 [TBL] [Abstract][Full Text] [Related]
10. Protein folding and its implications for the production of recombinant proteins. Hlodan R; Craig S; Pain RH Biotechnol Genet Eng Rev; 1991; 9():47-88. PubMed ID: 1797019 [No Abstract] [Full Text] [Related]
11. Droplets as reaction compartments for protein nanotechnology. Devenish SR; Kaltenbach M; Fischlechner M; Hollfelder F Methods Mol Biol; 2013; 996():269-86. PubMed ID: 23504430 [TBL] [Abstract][Full Text] [Related]
12. Protein expression -- CHI's Ninth Annual Conference -- optimizing protein expression. Marchal-Gerez I IDrugs; 2006 Mar; 9(3):174-6. PubMed ID: 16523379 [No Abstract] [Full Text] [Related]
13. Mating antibody phage display with proteomics. Hust M; Dübel S Trends Biotechnol; 2004 Jan; 22(1):8-14. PubMed ID: 14690617 [No Abstract] [Full Text] [Related]
14. Overview of approaches to preventing and avoiding proteolysis during expression and purification of proteins. Ryan BJ; Henehan GT Curr Protoc Protein Sci; 2013 Feb; Chapter 5():Unit5.25. PubMed ID: 23377852 [TBL] [Abstract][Full Text] [Related]
15. Digital imaging spectroscopy for massively parallel screening of mutants. Youvan DC; Goldman E; Delagrave S; Yang MM Methods Enzymol; 1995; 246():732-48. PubMed ID: 7752945 [No Abstract] [Full Text] [Related]
17. Stabilization of protein structures. Lee B; Vasmatzis G Curr Opin Biotechnol; 1997 Aug; 8(4):423-8. PubMed ID: 9265720 [TBL] [Abstract][Full Text] [Related]
18. Gene expression response to misfolded protein as a screen for soluble recombinant protein. Lesley SA; Graziano J; Cho CY; Knuth MW; Klock HE Protein Eng; 2002 Feb; 15(2):153-60. PubMed ID: 11917152 [TBL] [Abstract][Full Text] [Related]
19. While-you-wait proteins? Producing biomolecules at the point of need. Mohr BP; Retterer ST; Doktycz MJ Expert Rev Proteomics; 2016 Aug; 13(8):707-9. PubMed ID: 27402489 [No Abstract] [Full Text] [Related]
20. The use of recombinant methods and molecular engineering in protein crystallization. Derewenda ZS Methods; 2004 Nov; 34(3):354-63. PubMed ID: 15325653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]